ReviewPublished 12 October 2026Tebentafusp induces systemic immune activation, but tumor immune remodeling remains incompletely validated: a narrative review in metastatic uveal melanomaFrancesca Rifaldi · Filippo De Braud · Michele Del Vecchio · Lorenza Di GuardoFrontiers in Immunologydoi 10.3389/fimmu.2026.1934256
Original ResearchPublished 12 October 2026Early dynamics of eosinophils and the neutrophil-to-lymphocyte ratio are associated with severe immune-related adverse events during nivolumab therapy for metastatic renal cell carcinomaOndřej Fiala · Jan Králíček · Jindřich Kopecký · Michal Vočka · Tomas Buchler · Hana Študentová · Jana Obertová · Beáta Rondzíková · Martin Matějů · Dominik Šafčák · Matej Hrnčár · Peter Priester · Martina Spisarová · Anežka Zemánková · Radka Lohynská · Michaela Tkadlecová · Lucie Grmelová · Petr Stránský · Bohuslav Melichar · Patrik Palacka · Alexandr PoprachFrontiers in Immunologydoi 10.3389/fimmu.2026.1944728
Original ResearchPublished 16 February 2026Evaluation of host-immune biomarker signatures as multiplex qPCR diagnostic assays: a pilot study toward meeting WHO target product profiles for TB diagnosis in IndiaHarriet N. Garlant · Kalaiarasan Ellappan · Noyal Mariya Joseph · Carrie Turner · Vishnukanth Govindaraj · Saka Vinod Kumar · Sanjeev Kumar · Seshadri Vasan · Karen E. KempsellFrontiers in Tuberculosisdoi 10.3389/ftubr.2025.1678039
